BioCentury
ARTICLE | Company News

American CryoStem, Protein Genomics deal

November 18, 2013 8:00 AM UTC

American CryoStem and Protein Genomics formed a JV, Autogenesis Corp., to develop wound healing products and cellular therapies. The 50/50 collaboration will combine Protein Genomics' Elastatropin human-based protein materials with American CryoStem's ACSelerate cell media culture products and ATcells, which are adipose-derived regenerative cells. Elastatropin products use synthesized human tropoelastin, a precursor to elastin. Autogenesis will own future IP developed with the combination of the technologies. ...